噻呋酰胺  分析标准品

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

件 库存{{model.attbuying.number}}件
包装规格:100mg in glass bottle
产品简介:一种广谱的琥珀酸脱氢酶抑制剂杀真菌剂,被广泛用于控制稻田中的各种真菌疾病。 Thifluzamide is a succinate dehydrogenase inhibitor (SDHI) with strong antifungal activity.
溶解性:溶于DMSO(≥ 29 mg/mL)
储备液保存:-80°C, 2 years; -20°C, 1 year。
体外研究:Thifluzamide (0.01-0.4 μg/mL; 4-5 d) 可抑制田间分离的 Rhizoctonia cerealis 菌株的菌丝生长,EC50 为 0.064 μg/mL。 Thifluzamide (1-200 μg/mL) 处理可诱导获得 2 株 Rhizoctonia cerealis 突变体,分别具有高抗性 (RF=120) 和中等抗性 (RF=40)。 Rhizoctonia cerealis 突变体 WX14-1 和 WX14-2 对 Thifluzamide 的抗性在无杀菌剂转接 10 代后仍保持稳定;与野生型 Rhizoctonia cerealis 菌株 WX14 相比,这些突变体在菌丝生长、致病力或菌核产生方面均无适合度代价。
体内研究:Thifluzamide (0.019-1.90 mg/L; 28 d) 会干扰成年斑马鱼的脂质代谢,通过抑制脂肪酸合成、增强脂肪酸氧化来降低肝脏 TG 和 TCHO 水平,其中 1.90 mg/L 剂量下的作用最为显著。
动物实验:Animal Model:Danio rerio Zebrafish (adult, approximately five months old) Dosage:0.019 mg/L; 0.19 mg/L; 1.90 mg/L Administration:aqueous exposure; continuous; 28 days (daily solution refreshment) Result:Decreased condition factor to 0.84-fold of the control at 1.90 mg/L. Decreased hepatic triglyceride (TG) content to 0.56-fold, 0.51-fold, and 0.36-fold of the control at 0.019 mg/L, 0.19 mg/L, and 1.90 mg/L, respectively. Decreased hepatic total cholesterol (TCHO) content to 0.68-fold and 0.62-fold of the control at 0.19 mg/L and 1.90 mg/L, respectively. Detected no accumulation of lipid droplets in the liver at any dose. Decreased fatty acid synthetase (FAS) activity to 0.76-fold and 0.81-fold of the control at 0.19 mg/L and 1.90 mg/L, respectively; no change at 0.019 mg/L. Increased carnitine palmitoyltransferase (CPT-I) activity by 1.21-fold and 1.29-fold of the control at 0.19 mg/L and 1.90 mg/L, respectively; no change at 0.019 mg/L. Observed no apparent changes in hepatic lipase (HL) or lipoprotein lipase (LPL) activities at any dose.
保存条件:-20℃